5-iodo-a-85380, an α4β2 subtype-selective ligand for nicotinic acetylcholine receptors

Molecular Pharmacology

Volumn 57, Issue 3, 2000, Pages 642-649

  Mukhin, Alexey G ^a   Gündisch, Daniela ^a   Horti, Andrew G ^a   Koren, Andrei O ^a   Tamagnan, Gilles ^b   Kimes, Alane S ^a   Chambers, Joann ^a   Vaupel, D Bruce ^a   King, Sarah L ^b   Picciotto, Marina R ^b   Innis, Robert B ^b   London, Edythe D ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 IODO 3 (AZETIDINYLMETHOXY)PYRIDINE; IODINE 123; IODINE 125; NICOTINIC RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0342905448     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.57.3.642     Document Type: Article

References (40)

1. Abreo MA, Lin NH, Garvey DS, Gunn DE, Hettinger AM, Wasicak JT, Pavlik PA, Martin YC, Donnelly-Robert DL, Anderson DJ, Sullivan JP, Williams M, Arneric SP and Holladay MW (1996) Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. J Med Chem 39:817-825.
2. Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P and Garvey DS (1994) (S)-3-Methyl-5-(1-methyl-2-pyrrolidinybisoxazole (ABT 418k A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. J Pharmacol Exp Ther 270:310-318.
3. Bannon AW, Decker MW, Holladay MW, Curzon P, Donnelly-Robert DL, Puttfarcken PS, Bitner RS, Diaz A, Dickenson AH, Porsolt RD, Williams M and Arneric SP (1998) Broad-spectrum, non-opinid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science (Wash DC) 279:77-81.
4. Bougis PE, Marchot P and Rochat H (1986) Characterization of elapidae snake venom components using optimized reverse-phase high-performance liquid chromatographic conditions and screening assays for alpha-neurotoxin and phospholipase A2 activities. Biochemistry 25:7235-7243.
5. 123I]iodo-A-85380 using single photon emission computed tomography. Life Sci 63:PL355-PL360.
6. Criado M, Domínguez del Toro E, Carrasco-Serrano C, Smillie FI, Juíz JM, Viniegra S and Ballesta JJ (1997) Differential expression of α-bungarotoxin-sensitive neuronal nicotinic receptors in adrenergic chromaffin cells: A role for transcription factor Egr-1. J Neurosci 17:6554-6564.
7. 125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J Pharmacol Exp Ther 282:445-451.
8. Decker MW, Brioni JD, Bannon AW and Americ SP (1995) Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics. Life Sci 56:545-570.
9. Dukat M, Damaj MI, Glassco W, Duman D, May EL, Martin BR and Glennon RA (1993) Epibatidine: A very high affinity nicotine-receptor ligand. Med Chem Res 4:131-139.
10. Flores CM, Dávila-García MI, Ulrich YM and Kellar KJ (1997) Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J Neurochem 69:2216-2219.
11. Flores CM, DeCamp RM, Kilo S, Rogers SW and Hargreaves KM (1996) Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: Demonstration of α3β4, a novel subtype in the mammalian nervous system. J Neurosci 16:7892-7901.
12. Flores CM, Rogers SW, Pahreza LA, Wolfe BB and Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41:31-37.
13. Henderson LP, Gdovin MJ, Liu CL, Gardner PD and Maue RA (1994) Nerve growth factor increases nicotinic ACh receptor gene expression and current density in wild-type and protein kinase A-deficient PC12 Cells. J Neurosci 14:1153-1163.
14. Holladay MW, Dart MJ and Lynch JK (1997) Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J Med Chem 40:4169-4194.
15. 123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: A radioligand for nicotinic acetylcholine receptors. Nucl Med Biol 26:175-182.
16. 11C]methylated analogues of epibatidine as tracers for positron emission tomographic studies of nicotinic acetylcholine receptors. J Med Chem 41:4199-4206.
17. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48:280-287.
18. Koren AO, Horti AG, Mukhin AG, Gündisch D, Kimes AS, Dannals RF and London ED (1998) 2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: Synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J Med Chem 41:3690-3698.
19. Lindstrom JM (1995) Nicotinic acetylcholine receptors, in Handbook of Receptors and Channels: Ligand- and Voltage-Gated Ion Channels (North RA ed) pp 153-175, CRC Press, Boca Raton.
20. 3H]nicotine to a single class of high affinity sites in rat brain membranes. Mol Pharmacol 29:448-454.
21. Marks MJ, Smith KW and Collins AC (1998) Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J Pharmacol Exp Ther 285: 377-386.
22. Molina PE, Ding YS, Carroll I, Liang F, Volkow ND, Pappas N, Kuhar M, Abumrad N, Gatley SJ and Fowler JS (1997) Fluoro-norchloreoepibatidine: Preclinical assessment of acute tonicity. Nucl Med Biol 24:743-747.
23. Musachio JL, Horti A, London ED and Dannals RF (1997) Synthesis of a radioiodinated analog of epibatidine: (±)-exo-2-(2-iodo-5-pyridyl)-7-azabicyclo[2.2.1]heptane for in vitro and in vivo studies of nicotinic acetylcholine receptors. J Labelled Cmp Radiopharm 39:39-48.
24. 123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors. Life Sci 82:PL351-PL357.
25. Musachio JL, Villemagne VL, Scheffel UA, Dannals RF, Dogan AS, Yokoi F and Wong DF (1999) Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon. Nucl Med Biol 26:201-207.
26. 11C]nicotine in the human brain: Difficulties in visualizing specific receptor binding in vivo. Psychopharmacology (Berl) 115:31-36.
27. 3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol Pharmacol 39:9-12.
28. 3H]Epibatidine labels nicotinic receptors in rat brain: An autoradiographic study. J Pharmacol Exp Ther 275:1030-1034.
29. Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, LeNovere N, Vincent P, Pich EM, Brulet P and Changeux J-P (1995) Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature (Lond) 374:65-67.
30. Quik M, Choremis J, Komourian J, Lukas RJ and Puchacz E (1996) Similarity between rat brain nicotinic α-bungarotoxin receptors and stably expressed α-bungarotoxin binding sites. J Neurochem 67:145-154.
31. Rogers SW, Mandelzys A, Deneris ES, Cooper E and Heinemann S (1992) The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF. J Neurosci 12:4611-4623.
32. 3H]epibatidine in vitro autoradiography. Neuroscience 85:1121-1133.
33. Stauderman KA, Mahaffy LS, Akong M, Veliçelebi G, Chavez-Noriega LE, Crona JH, Johnson EC, Elliott KJ, Gillespie A, Reid RT, Adams P, Harpold MM and Corey-Naeve J (1998) Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations α2β4, α3β4 and α4β4 stably expressed in HEK293 cells. J Pharmacol Exp Ther 284:777-789.
34. Sullivan JP, Donnelly-Robert DL, Briggs CA, Anderson DJ, Gopalakrishnan M, Piattoni-Kaplan M, Campbell JE, McKenna DG, Molinari E, Hettinger AM, Garvey DS, Wasicak JT, Holladay MW, Williams M and Arneric SP (1996) A-85380 [3-(2(S)-Azetidinylmethoxy) pyridine]: In vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligand. Neuropharmacolngy 35:725-734.
35. 125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand. NeuroReport 9:2311-2317.
36. Wenger BW, Bryant DL, Boyd RT and McKay DB (1997) Evidence for spare nicotinic acetylcholine receptors and a β4 subunit in bovine adrenal chromaffin cells: Studies using bromoacetylcholine, epibatidine, cytisine and mAb35. J Pharmacol Exp Ther 281:905-913.
37. Whiteaker P, Sharpies CG and Wonnacott S (1998) Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: Pharmacological and spatial definition. Mol Pharmacol 53:950-962.
38. Xiao Y, Meyer EL, Thompson JM, Surin A, Wroblewski J and Kellar KJ (1998) Rat α3β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: Pharmacology of ligand binding and function. Mol Pharmacol 64:322-333.
39. Zeghloul S, Marchot P, Bougis PE and Ronin C (1988) Selective loss of binding sites for the iodinated α-neurotoxin I from Naja mossambica mossanibica venom upon enzymatic deglycosylation of Torpedo electric organ membranes. Eur J Biochem 174:543-550.
40. Zoli M, Léna C, Picciotto MR and Changeux J-P (1998) Identification of four classes of brain nicotinic receptors using β2 mutant mice. J Neurosci 18:4461-4472.